EUVIMED · CrossrefZeitschrift
Medicinal Chemistry Research
ISSN 1054-2523 · Springer Science and Business Media LLC
Neueste Artikel
New diterpenoids from Croton L. species (2019–2025): structural diversity and bioactivity
Mushroom-derived metabolites: a promising source of novel lead compounds for pharmaceutical and functional food applications
Brepocitinib (Lisraya®), a first orally administered small molecule dual TYK2/JAK1 inhibitor approved for dermatomyositis in adults
Camizestrant (Etcamah®): an oral estrogen receptor degrader and estrogen receptor antagonist approved for breast cancer
Remibrutinib (Rhapsido®), a covalent Bruton’s tyrosine kinase inhibitor approved for chronic spontaneous urticaria
Zidebactam as a new approved β-Lactamase inhibitor with intrinsic antibacterial activity via PBP2 binding
Unveiling the therapeutic potential of Calotropis procera: from traditional applications to phytochemistry, pharmacology, and safety
O-methylation of phenolic natural products: translational insights from resveratrol
Peptide-based allosteric modulators of AMPA receptors: design, docking and ligand-receptor interactions
Artificial intelligence–assisted lead optimization in drug discovery: bridging computational advances and translational challenges
Effect of pipernonaline from Piper retrofractum on memory disorder in mice and neurite outgrowth activity of PC12 cells
Probing novel azole–sulfonamide urea/thiourea conjugates as multitarget inhibitors of AChE and hCAs (I and II): synthesis, in vitro, and in silico studies
Baxdrostat (Baxfendy®), a first-in-class aldosterone synthase inhibitor approved for adults with uncontrolled hypertension
Repurposing antifolates as G9a methyltransferase inhibitors for potential Alzheimer’s disease therapeutics via 3D QSAR/pharmacophore mapping and experimental validations
Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation
Design and biological evaluation of sulfonamide–chalcone hybrids with in vitro tumor-selective cytotoxicity against oral squamous cell carcinoma: SAR, QSAR, and in silico ADME studies
Glypican-3-targeted bioconjugates for hepatocellular carcinoma: design, engineering, and translational applications
Optimization of a bis-imine scaffold as a glyoxalase I inhibitor: synthesis, SAR, and docking studies
Investigation of reported small molecule P2Y6 receptor antagonists
Special issue of Medicinal Chemistry Research in honor of Dr. Kenneth A. Jacobson
Review of promising benzimidazole-based anticancer agents (2023-2026)
Advances in quercetin-based therapeutics for breast cancer: natural, synthetic, and nanotechnology-driven approaches
The evolution of Nutlins as p53-MDM2 inhibitors
Natural products in medicinal chemistry: targeting inflammatory pathways with plant-derived compounds
Carbon atom σ-hole tetrel bonding – a non-bonded interaction with potential application in drug design
Targeting west nile virus replication by xanthine inhibitors
How fast can you invent a medicine?
Biocatalytic potential of microbial CYP450s in the degradation of selected environmental pollutants
Silibinin: a natural flavonoid with multifaceted anticancer potential and therapeutic challenges
An updated review on phytochemical and pharmacological potential of Portulaca oleracea L.
EUVIMED